OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NBIX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NBIX is expected to report earnings to fall 5.45% to $1.56 per share on November 04

Neurocrine Biosciences NBIX Stock Earnings Reports

Q3'25

Est.

$1.56

Q2'25

Beat

by $0.69

Q1'25

Missed

by $0.07

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.29

The last earnings report on July 30 showed earnings per share of $1.65, beating the estimate of 95 cents. With 449.62K shares outstanding, the current market capitalization sits at 13.78B.

View a ticker or compare two or three

Compare

NBIX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NBIX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBIX showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12780 El Camino Real

Phone

+1 858 617-7600

Employees

1400

Web

https://www.neurocrine.com